01 Rising Demand for Minimally Invasive Bunion Correction Surgeries The rising demand for minimally invasive bunion correction surgeries is reshaping the market, driven by the clear advantages these procedures offer. Patients and surgeons alike are increasingly favoring minimally invasive techniques due to their ability to reduce pain, speed up recovery, minimize scarring, and lower the risk of complications. These modern approaches, which use shorter incisions, are proving to deliver superior outcomes compared to traditional open surgeries, making them the go-to choice for bunion correction. For example, in December 2022, Arthrex launched the Arthrex Minimally Invasive Bunionectomy System, providing a cutting-edge alternative to conventional bunion surgery. This all-inclusive system is designed to facilitate precise, minimally invasive procedures that not only deliver clinically proven outcomes but also match or exceed the effectiveness of open surgeries. Such innovations in minimally invasive surgery offer patients faster recovery and improved outcomes, which are boosting the market growth.
September 2025 HyperFlex Medical Inc. announced the first patient treated in the clinical evaluation of the HyperFlex® Bunion Correction System. The milestone marked the advancement of the company's next-generation implant designed for early intervention in hallux valgus correction, supporting faster recovery while preserving joint motion.
June 2025 OSSIO Inc. launched its OSSIOfiber® Small Suture Anchors, expanding its portfolio of bio-integrative, metal-free orthopedic fixation implants for foot and ankle procedures. The launch strengthened the company's minimally invasive orthopedic offerings and complemented its bunion correction solutions by enhancing soft tissue fixation capabilities.